Why Do We Need Recombinant Proteins

Researchers broadly proclaim proteins as the quintessential contraption of biological systems. Their role in cell biology, specifically nutrient uptake, apoptosis, and cell growth and proliferation, has been an object of much interest. Recombinant proteins play a significant role in promoting living cells. These essential yet complex biomolecules are made of chains of acids. The proteins provide a host of benefits to body tissues and cells. The critical functions include promoting cell growth and development and augmenting physical attributes in humans. The protein is consummately produced by leading pharmaceutical manufacturers for tissue engineering and as enzymes and antibodies for treating diseases, among other functions. Since 2006, Shenandoah Biotechnology has been at the forefront of developing and supplying well-researched and cost-efficient recombinant proteins. See what are recombinant proteins here and their implications in human health and wellness.

The Making Of Recombinant Proteins And Why We Need Them

The Recombinant protein is classified as a manipulative protein variety with a trifecta effect. It can modify gene sequences, increase protein production, and produce essential commercial products for biochemistry and other purposes. The production of Recombinant proteins begins at the genetic level. During this stage, the protein-coding sequence is isolated and cloned to create a vector expressing plasmid. Studies show most Recombinant proteins used in life sciences and for therapeutic purposes are derived from humans. However, these proteins are carefully expressed in microbes such as animal cells in culture, Yeast, and bacteria. There are solid, scientifically backed reasons why Recombinant proteins are expressed in different life forms other than humans.

These include cost-effectiveness and enhanced production speed, and scale. It is essential to recognize that proteins co-expressed in bacteria do not feature glycosylation or phosphorylation induced post-translational modifications. Human genes are also known to be naturally complex, and this poses some challenges to science. The presence of introns, a non-coding DNA sequence, is a case in point. For seamless expression, intron-free generates may be needed, and these are produced by converting RNA to cDNA. The latter is free of regulatory bodies, terminator sequences, and ribosome-binding sites. With advances in cell biology, scientists have managed to create efficient tools to proliferate protein production. The development has seen mammalian cells being tapped to produce high volumes of therapeutic proteins with a similar operational mechanism as the naturally produced protein forms.

The Uses Of Recombinant Proteins

A lot of biomedical research has gone into finding the uses of Recombinant proteins in promoting health and fighting disease-causing microbes. Recombinant protein offers a perfect backdrop for understanding interactions between protein and protein and exploitation of the cellular processes. Techniques like RP microarrays are now widely used by researchers to study protein-protein interactions as well protein interactions with elements like lipids, enzymes, and nucleic acids. Other exploratory techniques used by leading laboratories include Immunohistochemistry and ELISA. Recombinant proteins are widely utilized to instigate cellular responses to diseases and stress. A case in point is the administration of Recombinant proteins on animal models to find suitable candidates for new therapeutic tests. Scientists are also testing the usefulness of Recombinant protein in biotherapeutics.

The biotherapeutics field of science is concerned with the production of drug therapy products extracted from various life forms. The study is critical because many diseases affecting humans are either fully or partially linked to protein dysfunction. That has not come as a surprise since many of the developed therapeutic proteins are deployed to deliver life-saving therapies for diseases such as hemophilia, cancer, and infectious diseases. Genetic engineering plays a pivotal role in promoting the mass production of human proteins. Recombinant protein was first hived for medicinal purposes in 1982 when Recombinant human insulin was produced.  The medication showed little or no serious side effects and strengthened the resolve of players in the biotechnology industry to explore its potential. Due to the early successes, the FDA has approved many Preclinical Research trials involving Recombinant protein.

A Brief On Recombinant Protein Indications

Some of the Recombinant proteins widely used in clinical trials include interleukins, blood clotting factors, interferon, and recombinant hormones. Clinical trials involving the protein are targeting debilitating diseases and conditions such as Crohn’s disease, anemia, congestive heart failure, and thrombocytopenia. Besides creating drugs, advanced biotechnology has also made it possible to explore the health benefits of Recombinant protein in improving central carbon mechanism and mapping and sequencing genes. Shenandoah Biotechnology has deployed massive resources in the production of Recombinant protein with the view of bringing the benefits closer to the people who need them most.